iShares Nasdaq US Biotechnology UCITS ETF ISIN IE00BYXG2H39, Ticker BTEK

 
Add to portfolio Watch Compare
 
 
 
 

Current quote and strategy of iShares Nasdaq US Biotechnology UCITS ETF

Investment strategy

The iShares Nasdaq US Biotechnology UCITS ETF seeks to track the Nasdaq Biotechnology index. The Nasdaq Biotechnology index tracks Nasdaq listed companies primarily engaged in biomedical research to develop new treatments and cures for human disease.

 

Nasdaq Biotechnology (3)

Equity (1132) United States (233) Health Care (8) Biotech (4)
 

Risk and fees of iShares Nasdaq US Biotechnology UCITS ETF

Risk
GBP 379 m
Fund size
Fund size category

Replication

Physical (Optimized sampling)
Legal structure ETF
Strategy risk Long-only
Fund currency USD

Currency risk

Currency unhedged
Volatility 1 year (in GBP) 26.44% Risk category
Inception/ Listing Date 19 October 2017
Fees
0.35% p.a.
Total expense ratio
0.04% Compare 1.38%
Compare ( Equity )
Dividend/ Taxes
Distribution policy Accumulating
Distribution frequency -
Fund domicile Ireland
Legal structure
Fund Structure Open-ended Investment Company (OEIC)
UCITS compliance Yes
Fund Provider iShares
Administrator State Street International Ireland Ltd
Investment Advisor
Custodian Bank State Street Custodial Services (Ireland) Limited
Revision Company Deloitte
Fiscal Year End 31 May
Swiss representative BlackRock Asset Management Schweiz AG
Swiss paying agent State Street Bank International GmbH, Munich, Zurich Branch
Tax Status
Germany 30% tax rebate
Switzerland ESTV Reporting
Austria Tax Reporting Fund
UK UK Reporting
Replication, swap, securities lending
Indextype Total return index
Swap counterparty -
Collateral manager Bank of New York Mellon|Euroclear|State Street Bank|JP Morgan
Securities lending Yes
Securities lending counterparty UBS AG|Deutsche Bank AG|Goldman Sachs International|BNP Paribas Arbitrage SNC|Merrill Lynch International|Citigroup Inc|BNP Paribas SA|Societe Generale SA|JP Morgan Chase & Co|The Bank of Nova Scotia|HSBC Bank Plc|Nomura International Plc|Macquarie Bank Limited|Credit Suisse Securities (Europe) Ltd.|Barclays Bank Plc|J.P. Morgan Securities Plc|Citigroup Global Markets Ltd|Morgan Stanley & Co. International Plc|Skandinaviska Enskilda Banken AB|Barclays Capital Securities Ltd.
 
 
 

Performance of iShares Nasdaq US Biotechnology UCITS ETF

Loading...
 
 

Exposure

Below you find information about the composition of the iShares Nasdaq US Biotechnology UCITS ETF.

Top 10 Holdings
Weight of top 10 holdings
out of 270
54.89%
AMGEN INC
8.34%
REGENERON PHARMACEUTICALS INC
8.30%
GILEAD SCIENCES INC
8.09%
VERTEX PHARMACEUTICALS ORD
7.63%
MODERNA INC
5.42%
ASTRAZENECA PLC ADR
3.97%
BIOGEN INC
3.78%
SEAGEN INC ORD
3.61%
ILLUMINA INC
3.38%
HORIZON THERAPEUTICS PLC
2.37%
Countries
United States
82.65%
Ireland
3.91%
Germany
1.27%
Other
12.17%
Sectors
Health Care
97.51%
Other
2.49%
As of 30/03/2023
 
 

Description of iShares Nasdaq US Biotechnology UCITS ETF

The iShares Nasdaq US Biotechnology UCITS ETF invests in stocks with focus Biotech, Health Care, United States. The dividends in the fund are reinvested (accumulating).

The total expense ratio amounts to 0.35% p.a.. The fund replicates the performance of the underlying index by buying a selection of the most relevant index constituents (sampling technique). The iShares Nasdaq US Biotechnology UCITS ETF has 379m GBP assets under management. The ETF is older than 5 years and is domiciled in Ireland.
 

Look for similar ETFs

 
 

Returns of iShares Nasdaq US Biotechnology UCITS ETF

Returns in years
Loading...
Returns in periods
Loading...
 
Monthly returns in a heat map
Loading...
 
 

Listings of iShares Nasdaq US Biotechnology UCITS ETF

Loading...
 

Rolling 1 year volatility of iShares Nasdaq US Biotechnology UCITS ETF

Loading...
 
Volatility 1 year Volatility 3 years Volatility 5 years
26.44% 25.74% 26.74%
Return per risk 1 years Return per risk 3 years Return per risk 5 years
0.62 0.05 0.21
 

Frequently asked questions

What is the name of BTEK?

The name of BTEK is iShares Nasdaq US Biotechnology UCITS ETF.

What is the ticker of iShares Nasdaq US Biotechnology UCITS ETF?

The primary ticker of iShares Nasdaq US Biotechnology UCITS ETF is BTEK.

What is the ISIN of iShares Nasdaq US Biotechnology UCITS ETF?

The ISIN of iShares Nasdaq US Biotechnology UCITS ETF is IE00BYXG2H39.

What are the costs of iShares Nasdaq US Biotechnology UCITS ETF?

The total expense ratio (TER) of iShares Nasdaq US Biotechnology UCITS ETF amounts to 0.35% p.a.. These costs are withdrawn continuously from the fund assets and already included in the performance of the ETF. You don't have to pay them separately. Please have a look at our article for more information about the cost of ETFs.

Is iShares Nasdaq US Biotechnology UCITS ETF paying dividends?

iShares Nasdaq US Biotechnology UCITS ETF is an accumulating ETF. This means that dividends are not distributed to investors. Instead, dividends are reinvested in the fund on the ex-date, which leads to an increase of the ETF's share price.

What's the fund size of iShares Nasdaq US Biotechnology UCITS ETF?

The fund size of iShares Nasdaq US Biotechnology UCITS ETF is 379m GBP. See the following article for more information about the size of ETFs.

Track your ETF strategies online

 
— Data provided by Trackinsight, etfinfo, Xignite Inc. and justETF GmbH.

All quotes are 15 minutes delayed stock exchange quotes or NAVs (=daily published by fund provider). Returns include dividend payments. There is no warranty for completeness, accuracy and correctness for the displayed information.